Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)
PET-Magnetic Resonance (MR) Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With [64]Cu-25%CANF-Comb (Volunteer - BioDistribution and Safety Study)
Status: Enrolling
Updated:  12/14/2015
Washington University in St.Louis
mi
from
St.Louis, MO
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)
PET-Magnetic Resonance (MR) Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With [64]Cu-25%CANF-Comb (Volunteer - BioDistribution and Safety Study)
Status: Enrolling
Updated: 12/14/2015
Washington University in St.Louis
mi
from
St.Louis, MO
Click here to add this to my saved trials
Diet and Systemic Inflammation
Diet and Systemic Inflammation
Status: Enrolling
Updated:  12/15/2015
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Diet and Systemic Inflammation
Diet and Systemic Inflammation
Status: Enrolling
Updated: 12/15/2015
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Effect of Probiotic Supplementation on Endothelial Function
Effect of Probiotic Supplementation on Endothelial Function in Men With Coronary Artery Disease
Status: Enrolling
Updated:  12/15/2015
Medical College of Wisconsin
mi
from
Milwauke, WI
Effect of Probiotic Supplementation on Endothelial Function
Effect of Probiotic Supplementation on Endothelial Function in Men With Coronary Artery Disease
Status: Enrolling
Updated: 12/15/2015
Medical College of Wisconsin
mi
from
Milwauke, WI
Click here to add this to my saved trials
Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders
Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders
Status: Enrolling
Updated:  12/15/2015
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders
Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders
Status: Enrolling
Updated: 12/15/2015
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion
The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion
Status: Enrolling
Updated:  12/17/2015
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion
The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion
Status: Enrolling
Updated: 12/17/2015
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
Status: Enrolling
Updated:  12/18/2015
University of Chicago
mi
from
Chicago, IL
Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
Status: Enrolling
Updated: 12/18/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #011
mi
from
Birmingham, AL
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #011
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #018
mi
from
La Jolla, CA
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #018
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
Newport Beach, CA
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
Fairfield, CT
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
Fairfield, CT
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
Atlantis, FL
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #015
mi
from
Fort Lauderdale, FL
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #015
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
Decatur, GA
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
Decatur, GA
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #146
mi
from
Lexington, KY
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #146
mi
from
Lexington, KY
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
Boston, MA
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #017
mi
from
Saginaw, MI
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #017
mi
from
Saginaw, MI
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
Great Falls, MT
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
Great Falls, MT
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #140
mi
from
Reno, NV
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #140
mi
from
Reno, NV
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
New Brunswick, NJ
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
Buffalo, NY
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
West Haverstraw, NY
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
West Haverstraw, NY
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
White Plains, NY
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
White Plains, NY
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #5048
mi
from
Charlotte, NC
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #5048
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Investigational Site
mi
from
Philadelphia, PA
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #183
mi
from
Norfolk, VA
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #183
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated:  12/18/2015
Acorda Site #010
mi
from
Bellevue, WA
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Status: Enrolling
Updated: 12/18/2015
Acorda Site #010
mi
from
Bellevue, WA
Click here to add this to my saved trials
Education and Counseling for Abstinence From Tobacco After Pregnancy
Postpartum Maintenance of Abstinence From Tobacco
Status: Enrolling
Updated:  12/21/2015
Brown University
mi
from
Providence, RI
Education and Counseling for Abstinence From Tobacco After Pregnancy
Postpartum Maintenance of Abstinence From Tobacco
Status: Enrolling
Updated: 12/21/2015
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Status: Enrolling
Updated:  12/21/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Status: Enrolling
Updated: 12/21/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Arkansas Heart Hospital
mi
from
Little Rock, AR
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Glendale Adventist Medical Center
mi
from
Glendale, CA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Glendale Adventist Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
The Hartford Hospital
mi
from
Hartford, CT
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
MedStar Washington Hospital
mi
from
Washington,
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
MedStar Washington Hospital
mi
from
Washington,
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Clearwater Cardiovascular & Interventional Consultants, MD, PA
mi
from
Clearwater, FL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Clearwater Cardiovascular & Interventional Consultants, MD, PA
mi
from
Clearwater, FL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Mount Sinai Medical Center Heart Institute
mi
from
Miami Beach, FL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Mount Sinai Medical Center Heart Institute
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Cardiovascular Institute of NW Florida
mi
from
Panama City, FL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Cardiovascular Institute of NW Florida
mi
from
Panama City, FL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Georgia Regents Research Institute
mi
from
Augusta, GA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Georgia Regents Research Institute
mi
from
Augusta, GA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Indiana University
mi
from
Indianapolis, IN
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
John Hopkins
mi
from
Baltimore, MD
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
John Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Tufts Medical Center
mi
from
Boston, MA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Baystate Medical Center
mi
from
Springfield, MA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
McLaren Bay Regional
mi
from
Bay City, MI
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
McLaren Bay Regional
mi
from
Bay City, MI
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Beaumont Hospital
mi
from
Royal Oak, MI
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Boone Hospital
mi
from
Columbia, MO
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Boone Hospital
mi
from
Columbia, MO
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Saint Luke's
mi
from
Kansas City, MO
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Saint Luke's
mi
from
Kansas City, MO
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Barnes Jewish Hospital
mi
from
St. Louis, MO
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Hackensack University Medical Center
mi
from
Hackensack, NJ
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Jersey Shore Medical Center
mi
from
Neptune, NJ
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Jersey Shore Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials